Conversation tool for older adults with advanced chronic kidney disease choosing treatment
Tests a conversation aid for older adults with advanced kidney disease and clinicians.
Plain-language title generated from the registry record
Registry title: A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
Key facts
- Where
- Hong Kong, Hong KongSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for older adults with advanced kidney disease (stage 4 or 5) and the kidney doctors who care for them. It tests a tool that helps patients and doctors decide on treatment together.
- Age
- 65 years or older
- Sex
- All sexes can join.
- Disease stage
- Advanced chronic kidney disease, stage 4 or 5: eGFR of 20 or lower and creatinine of 350 umol/L (3.96 mg/dL) or higher on two measurements at least 90 days apart in the prior year.
- Earlier treatment
- Patients cannot have a confirmed treatment decision for dialysis, palliative care or kidney transplant, and cannot have started any of these treatments.
- Biomarker or test result
- eGFR of 20 or lower and creatinine level of 350 umol/L (3.96 mg/dL) or higher on two measurements at least 90 days apart in the prior year.
Main reasons for not taking part
- A confirmed treatment decision for dialysis, palliative care or kidney transplant noted in the clinical notes
- Having already started dialysis, palliative care or a kidney transplant
- Not able to make decisions for themselves
Read by machine on 9 November 2026.
Where in Hong Kong
- Queen Mary HospitalHong Kong, Hong KongContact: Jacqueline KY YuenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- The University of Hong Kong
- Trial code
- NCT06799936
- Record updated
- 8 September 2026
- Original description
To achieve the goal of reaching consensus about the preferred treatment option that best aligns with the goals and values of patients, the investigators developed a 'CKD Jumpstart- Tips" priming tool tailored for older adults with advanced CKD that is based on communication principles from VitalTalk and Elwyn's goal-based SDM model.Read full original descriptionShow less
A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced Chronic Kidney Disease and Clinicians: A Cluster-Randomized Controlled Trial
To achieve the goal of reaching consensus about the preferred treatment option that best aligns with the goals and values of patients, the investigators developed a 'CKD Jumpstart- Tips" priming tool tailored for older adults with advanced CKD that is based on communication principles from VitalTalk and Elwyn's goal-based SDM model.
The investigators hypothesize that compared with patients in the usual care group, patients in the 'CKD Jumpstart- Tips' intervention group will have:
1. increased level of shared decision-making (observer-based and patient-reported), 2. improved quality of communication, 3. increased patient involvement in decision-making, 4. lower decisional conflict, 5. lower decision regret, 6. decreased time to decision, 7. improved adherence to treatment choice, and 8. improved health-related quality-of-life.
Inclusion: Clinicians; Nephrology specialists or higher physician trainees who provide specialty care to older adults with advanced chronic kidney disease; Patients; Diagnosis of advanced CKD Stage 4 or 5 defined by estimated Glomerular Filtration Rate (eGFR) of ≤ 20 and a creatinine level ≥350 (umol/L) on two measurements at least 90 days apart in the prior year; Chinese- or English-speaking; Able to provide written informed consent and complete questionnaires; Can be contacted by phone.
Exclusion: have a confirmed advanced CKD treatment decision for dialysis, palliative care, or renal transplant documented in clinical notes; Patients will be excluded if they; have initiated any of these treatments; lack decision-making capacity.